Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
This Article
Right arrow Abstract
Right arrow Full Text
Right arrow Submit a response
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrowRequest Permissions
Rimonabant, a Selective Cannabinoid CB1 Receptor Antagonist, Inhibits Atherosclerosis in LDL Receptor–Deficient Mice
Arterioscler Thromb Vasc Biol Dol-Gleizes et al. 29: 12

Data Supplement

Files in this Data Supplement:





This Article
Right arrow Abstract
Right arrow Full Text
Right arrow Submit a response
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrowRequest Permissions